Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

2014 – Scientists: “Literature suggests an increased risk of new-onset diabetes” with statin drugs

Posted in Lipitor

An article published in the March 2014 edition of Current Radiology Reports by CN Bang et al. titled “Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.” cites research linking statin use and new onset diabetes.  Statins are commonly-used cholesterol-lowering drugs including Lipitor, Zocor, Crestor, and many others.

Bang et al. (2014) state “The majority of the literature suggests an increased risk of new-onset diabetes in patients treated with statins in a number of different settings and that the risk appears greatest among the more potent statins.”  For clarity, Lipitor (atorvastatin) and Crestor (rosuvastatin) are commonly held as the most potent statin drugs available.

In addition to the risk of new onset diabetes associated with statins, this research team notes that “other side effects have been reported such as increased risk of myotoxicity, increased liver enzymes, cataracts, mood disorders, dementias, hemorrhagic stroke and peripheral neuropathy, which should maybe be added to the increased risk of new-onset diabetes, when considering the risk- benefit ratio of statin treatment.”

Due to the fact that many people have used Lipitor unaware of the risk for diabetes, a number of Lipitor diabetes lawsuits have been filed.  If you or a loved one used Lipitor and received a diabetes diagnosis, you may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Lipitor lawyers at the information provided below.  We have the experience, resources, and skills required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

justinian@dangerousdrugs.us

Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.